drugset / Trial / NCT00624975
Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants
Phase 2
Terminated
74 enrolled
International Vaccine Institute
Avant Immunotherapeutics · collabChristian Medical College, Vellore, India · collabInternational Centre for Diarrhoeal Disease Research, Bangladesh · collabVaccine Technologies Inc. · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to confirm the safety and immunogenicity of Peru-15 vaccine in infants when given simultaneously with measles vaccine.
Timeline
- Start
- 2008-11
- Primary completion
- 2012-07
- Completion
- 2012-07
Outcome
Outcome not reported
Stopped: “one of site was not able to get an approval from the national regulatory authority.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peru-15 | Vaccine | 1e+09 unknown | Oral |